Orthofix Medical Inc. reported $833M of revenue over the trailing twelve months, +3.0% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $833M (to Q2 2026). Net income: −$62M, trailing twelve months to Q2 2026. Free cash flow: −$28M, trailing twelve months to Q2 2026. Operating margin: −4.8%, trailing twelve months to Q2 2026.

OFIXOrthofix Medical Inc.

Healthcare

$9.01-37% 1Y

$9.01

$8.6552 weeks$16.23

OFIX as reported

Orthofix Medical Inc. reported $833M of revenue over the trailing twelve months, +3.0% on the year before. 11 reported series are charted on this page, each one as filed.

$833M

Revenue, trailing twelve months · to Q2 2026 · +3.0% against the twelve months before

Net income: −$62M
Net income · −50% year on year · trailing twelve months to Q2 2026
Free cash flow: −$28M
Free cash flow · −433% year on year · trailing twelve months to Q2 2026
Operating margin: −4.8%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for OFIX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$833M	+3.0%	Q2 2026
Net income	−$62M	−50%	Q2 2026
EPS	−$1.53	−52%	Q2 2026
Gross margin	71%	n/a	Q2 2026
Operating margin	−4.8%	n/a	Q2 2026
Net margin	−7.6%	n/a	Q2 2026
ROE	−19%	n/a	Q2 2026
ROA	−9.7%	n/a	Q2 2026
ROIC	−9.6%	n/a	Q2 2026
Free cash flow	−$28M	−433%	Q2 2026
P/E	123	n/a	Q2 2019 · 28 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.